Status:
COMPLETED
A Study to Learn About the Study Medicine - Precedex in Children From Japan.
Lead Sponsor:
Pfizer
Conditions:
Sedation
Eligibility:
All Genders
1-17 years
Brief Summary
The purpose of this study is to look at the safety of Precedex when it was used to calm children at procedures or tests under actual medical practice in Japan. This study is seeking for children who ...
Eligibility Criteria
Inclusion
- Pediatric patients (1 month to \< 18 years old) administered Precedex for "sedation of non-intubated pediatric patients for non-invasive procedures and tests"
Exclusion
- No exclusion criteria is set out in this study.
Key Trial Info
Start Date :
October 18 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2025
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT06085573
Start Date
October 18 2023
End Date
June 20 2025
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer
Toykyo, Japan, 151-8589